Jane Street’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$19.4M Buy
732,174
+545,528
+292% +$14.5M ﹤0.01% 522
2025
Q1
$4.51M Sell
186,646
-221,033
-54% -$5.34M ﹤0.01% 1465
2024
Q4
$16.4M Buy
407,679
+68,872
+20% +$2.77M ﹤0.01% 514
2024
Q3
$21.4M Sell
338,807
-44,525
-12% -$2.82M ﹤0.01% 405
2024
Q2
$20.3M Buy
383,332
+36,244
+10% +$1.92M ﹤0.01% 637
2024
Q1
$28.5M Sell
347,088
-3,152
-0.9% -$258K 0.01% 379
2023
Q4
$6.52M Buy
350,240
+97,241
+38% +$1.81M ﹤0.01% 1265
2023
Q3
$2.8M Sell
252,999
-289,071
-53% -$3.2M ﹤0.01% 1866
2023
Q2
$8.79M Buy
542,070
+184,425
+52% +$2.99M ﹤0.01% 1056
2023
Q1
$5.95M Buy
357,645
+299,830
+519% +$4.99M ﹤0.01% 1057
2022
Q4
$543K Buy
57,815
+44,908
+348% +$422K ﹤0.01% 3291
2022
Q3
$36K Sell
12,907
-15,734
-55% -$43.9K ﹤0.01% 5183
2022
Q2
$83K Sell
28,641
-12,217
-30% -$35.4K ﹤0.01% 4809
2022
Q1
$123K Buy
40,858
+18,225
+81% +$54.9K ﹤0.01% 4915
2021
Q4
$104K Sell
22,633
-7,904
-26% -$36.3K ﹤0.01% 4666
2021
Q3
$192K Buy
+30,537
New +$192K ﹤0.01% 4417
2021
Q2
Sell
-73,941
Closed -$467K 5808
2021
Q1
$467K Buy
73,941
+41,983
+131% +$265K ﹤0.01% 3425
2020
Q4
$180K Sell
31,958
-3,533
-10% -$19.9K ﹤0.01% 3507
2020
Q3
$207K Buy
35,491
+23,503
+196% +$137K ﹤0.01% 3205
2020
Q2
$86K Sell
11,988
-1,967
-14% -$14.1K ﹤0.01% 3700
2020
Q1
$65K Buy
13,955
+2,322
+20% +$10.8K ﹤0.01% 3206
2019
Q4
$93K Sell
11,633
-12,178
-51% -$97.4K ﹤0.01% 3105
2019
Q3
$164K Buy
23,811
+286
+1% +$1.97K ﹤0.01% 3106
2019
Q2
$196K Sell
23,525
-125,862
-84% -$1.05M ﹤0.01% 3137
2019
Q1
$1.49M Buy
+149,387
New +$1.49M ﹤0.01% 1346
2018
Q4
Sell
-128,065
Closed -$2.23M 3896
2018
Q3
$2.23M Buy
+128,065
New +$2.23M ﹤0.01% 1033